VIVEVE MEDICAL, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Viveve Medical, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2022.
  • Viveve Medical, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 9, 2022 was 10.7M shares, a 1.14% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 10.7M +121K +1.14% Nov 9, 2022 10-Q 2022-11-10
Q2 2022 10.7M +73.3K +0.69% Aug 10, 2022 10-Q 2022-08-11
Q1 2022 10.6M +278K +2.69% Mar 11, 2022 10-K 2022-03-17
Q3 2021 10.6M -11.1M -51% Nov 11, 2021 10-Q 2021-11-12
Q2 2021 10.6M -5.14M -32.7% Aug 11, 2021 10-Q 2021-08-12
Q1 2021 10.3M +314K +3.13% Mar 12, 2021 10-K 2021-03-18
Q3 2020 21.7M +20.2M +1366% Nov 10, 2020 10-Q 2020-11-12
Q2 2020 15.7M -30.9M -66.2% Aug 12, 2020 10-Q 2020-08-13
Q1 2020 10M -36.3M -78.4% Mar 13, 2020 10-K 2020-03-19
Q3 2019 1.48M -30.1M -95.3% Nov 6, 2019 10-Q 2019-11-07
Q2 2019 46.6M +15.1M +48% Aug 7, 2019 10-Q 2019-08-08
Q1 2019 46.4M +15.1M +48.4% Mar 8, 2019 10-K 2019-03-15
Q3 2018 31.5M +12.1M +62.4% Nov 7, 2018 10-Q 2018-11-08
Q2 2018 31.5M +12.1M +62.3% Aug 8, 2018 10-Q 2018-08-09
Q1 2018 31.2M +11.9M +61.4% Mar 8, 2018 10-K 2018-03-16
Q3 2017 19.4M +8.78M +82.4% Nov 7, 2017 10-Q 2017-11-08
Q2 2017 19.4M +8.8M +83% Aug 9, 2017 10-Q 2017-08-10
Q1 2017 19.4M -40.6M -67.7% May 10, 2017 10-Q 2017-05-11
Q4 2016 10.7M Feb 7, 2017 10-K 2017-02-16
Q3 2016 10.6M -40.7M -79.3% Nov 10, 2016 10-Q 2016-11-10
Q2 2016 10.6M -40.7M -79.3% Aug 10, 2016 10-Q 2016-08-11
Q1 2016 59.9M +41.6M +227% Mar 15, 2016 10-K 2016-03-24
Q3 2015 51.3M +33.3M +185% Nov 13, 2015 10-Q 2015-11-13
Q2 2015 51.3M -125M -70.8% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 18.3M -107M -85.3% Mar 10, 2015 10-K 2015-03-16
Q3 2014 18M -143M -88.8% Nov 11, 2014 10-Q 2014-11-14
Q2 2014 176M +109M +161% Aug 9, 2014 10-Q 2014-08-13
Q1 2014 125M +70.3M +128% Mar 14, 2014 10-K 2014-03-31
Q3 2013 161M +130M +407% Nov 6, 2013 10-Q 2013-11-14
Q2 2013 67.5M +36.1M +115% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 54.7M +24.4M +80.3% Mar 15, 2013 10-K 2013-03-29
Q3 2012 31.8M +1.46M +4.81% Nov 8, 2012 10-Q 2012-11-14
Q2 2012 31.4M +1.04M +3.43% Aug 13, 2012 10-Q 2012-08-14
Q1 2012 30.4M Mar 17, 2012 10-K 2012-03-30
Q3 2011 30.4M Nov 10, 2011 10-Q 2011-11-14
Q2 2011 30.4M Aug 8, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.